Endometrial cancer natural history, complications and prognosis
|
Endometrial cancer Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Endometrial cancer natural history, complications and prognosis On the Web |
|
American Roentgen Ray Society Images of Endometrial cancer natural history, complications and prognosis |
|
FDA on Endometrial cancer natural history, complications and prognosis |
|
CDC on Endometrial cancer natural history, complications and prognosis |
|
Endometrial cancer natural history, complications and prognosis in the news |
|
Blogs on Endometrial cancer natural history, complications and prognosis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing.
Overview
Natural History
Complications
- A perforation (hole) of the uterus may occur during a D&C or an endometrial biopsy.
Prognosis
Because endometrial cancer is usually diagnosed in the early stages (70 % to 75 % of cases are in stage 1 at diagnosis; 10 % to 15 % of cases are in stage 2; 10 % to 15 % of cases are in stage 3 or 4), there is a better probable outcome associated with it than with other types of gynecological cancers such as cervical or ovarian cancer. While endometrial cancers are 40% more common in Caucasian women, an African American woman who is diagnosed with uterine cancer is twice as likely to die, possibly due to the higher frequency of aggressive subtypes in that population.
Survival rates
The 5-year survival rate for endometrial cancer following appropriate treatment is:
- 75% to 95% for stage 1
- 50% for stage 2
- 30% for stage 3
- less than 5% for stage 4